CA
RMD icon

Cannon Advisors’s ResMed RMD Stock Holding History

Cannon Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857K Buy
+4,442
New +$921K 0.52% 46

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Cannon Advisors's RMD Position: Q2 2026 in Review

Cannon Advisors opened a new position in ResMed (RMD) in Q2 2026: 4,442 shares worth $857K. The stake represents 0.52% of the portfolio and ranks #46 among its holdings.

103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Cannon Advisors held 4,442 shares of ResMed worth $857K as of Q2 2026.
  • ResMed was a new Cannon Advisors position in Q2 2026.
  • ResMed made up 0.52% of Cannon Advisors's portfolio in Q2 2026, its #46 holding.
  • 103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Cannon Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.